FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$81.29 B | $100.33 B | $59.55 B | $63.63 B | $62.58 B | $63.32 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$34.41 B | $38.24 B | $29.21 B | $21.78 B | $18.57 B | $19.41 B |
Gross Profit Revenue minus cost of revenue. |
|
$46.88 B | $62.09 B | $30.34 B | $41.85 B | $44.01 B | $43.91 B |
|
Operating Expense
Costs to run business. 
|
|
$26.08 B | $24.54 B | $25.05 B | $25.36 B | $28.58 B | $29.06 B |
Operating Income Profit from operations. |
|
$20.79 B | $37.55 B | $5.29 B | $16.48 B | $15.44 B | $14.85 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$1.26 B | -$987.00 M | -$585.00 M | -$2.55 B | -$2.07 B | -$2.11 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$4.81 B | $1.58 B | $2.03 B | $5.37 B | $5.25 B | $4.06 B |
Total Other Income (Net) Net non-operating items. |
|
$3.52 B | -$2.82 B | -$4.23 B | -$8.46 B | -$7.92 B | -$6.94 B |
Income Before Tax Profit before taxes. |
|
$24.31 B | $34.73 B | $1.06 B | $8.02 B | $7.52 B | $7.91 B |
Income Tax Expense Taxes on income. |
|
$1.85 B | $3.33 B | -$1.11 B | -$28.00 M | -$266.00 M | $384.00 M |
|
Net Income
Final profit.
|
|
$22.15 B | $31.37 B | $2.13 B | $8.02 B | $7.77 B | $7.49 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$3.95 | $5.59 | $0.38 | $1.42 | $1.36 | $1.31 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$3.88 | $5.47 | $0.37 | $1.41 | $1.36 | $1.31 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
5.60 B | 5.61 B | 5.64 B | 5.66 B | 5.68 B | 5.69 B |
Diluted Average Shares Outst. Shares including dilution. |
|
5.71 B | 5.73 B | 5.71 B | 5.70 B | 5.69 B | 5.73 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$25.60 B | $35.97 B | $3.27 B | $11.11 B | $10.19 B | $10.79 B |
EBITDA Earnings before interest, tax, D&A. |
|
$30.79 B | $41.03 B | $9.56 B | $18.13 B | $15.10 B | $16.94 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$5.19 B | $5.06 B | $6.29 B | $7.01 B | $4.91 B | $6.16 B |
| Company Report |
FY 2025
Pfizer's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Pfizer's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Pfizer's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Pfizer's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
